These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20116834)

  • 1. Argatroban and renal replacement therapy in a morbidly obese patient with heparin-induced thrombocytopenia: a case report.
    Godier A; Flaujac C; Horellou MH; De Mesmay M; Bécanne X; Parisot M; Gauzit R; Samama CM
    Thromb Res; 2010 Aug; 126(2):e141-3. PubMed ID: 20116834
    [No Abstract]   [Full Text] [Related]  

  • 2. Argatroban anticoagulation for renal replacement therapy in patients with heparin-induced thrombocytopenia after cardiovascular surgery.
    Koster A; Hentschel T; Groman T; Kuppe H; Hetzer R; Harder S; Fischer KG
    J Thorac Cardiovasc Surg; 2007 May; 133(5):1376-7. PubMed ID: 17467467
    [No Abstract]   [Full Text] [Related]  

  • 3. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia requiring renal replacement therapy.
    Reddy BV; Grossman EJ; Trevino SA; Hursting MJ; Murray PT
    Ann Pharmacother; 2005 Oct; 39(10):1601-5. PubMed ID: 16131539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-induced thrombocytopenia in a pediatric patient receiving extracorporeal support and treated with argatroban.
    Scott LK; Grier LR; Conrad SA
    Pediatr Crit Care Med; 2006 May; 7(3):255-7. PubMed ID: 16474254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful Anticoagulation Using Argatroban During Transcatheter Aortic Valve Implantation in a Patient With Heparin-Induced Thrombocytopenia.
    Naganuma T; Mitomo S; Kin N; Nakamura S
    A A Case Rep; 2016 Oct; 7(7):158-60. PubMed ID: 27513970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacotherapy: argatroban--alternative to heparin in case of heparin-induced thrombocytopenia type II (HIT II)].
    Schönfeld H; Hein OV
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2006 Jun; 41(6):376-7. PubMed ID: 16804787
    [No Abstract]   [Full Text] [Related]  

  • 7. Argatroban anticoagulation in obese versus nonobese patients: implications for treating heparin-induced thrombocytopenia.
    Rice L; Hursting MJ; Baillie GM; McCollum DA
    J Clin Pharmacol; 2007 Aug; 47(8):1028-34. PubMed ID: 17525167
    [No Abstract]   [Full Text] [Related]  

  • 8. Argatroban for anticoagulation in continuous renal replacement therapy.
    Link A; Girndt M; Selejan S; Mathes A; Böhm M; Rensing H
    Crit Care Med; 2009 Jan; 37(1):105-10. PubMed ID: 19050602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. INR matters: a case on managing argatroban for bridging oral anticoagulation in a patient with heparin induced thrombocytopenia type II after mechanical heart valve replacement.
    Raaz U; Maegdefessel L; Buerke M; Janusch M; Werdan K; Schlitt A
    Thromb Res; 2009 Jun; 124(2):242-3. PubMed ID: 19019411
    [No Abstract]   [Full Text] [Related]  

  • 10. Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD.
    Dager WE; White RH
    Ann Pharmacother; 2003 Sep; 37(9):1232-6. PubMed ID: 12921505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombelastography in a patient with heparin-induced thrombocytopenia treated with argatroban.
    Zayac EA; Pivalizza EG; Levine RL
    Anesth Analg; 2008 Jan; 106(1):351-2. PubMed ID: 18165611
    [No Abstract]   [Full Text] [Related]  

  • 12. Argatroban as a heparin substitute in cases of heparin-induced thrombocytopenia.
    Shrager JB; Kaiser LR
    Ann Thorac Surg; 2004 Dec; 78(6):2208; author reply 2208-9. PubMed ID: 15561082
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diagnosis and treatment of heparin-induced thrombocytopenia].
    Link A; Pöss J; Böhm M
    Dtsch Med Wochenschr; 2011 May; 136(18):953-62; quiz 963-6. PubMed ID: 21526460
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of continuous veno-venous hemofiltration on argatroban clearance in a patient with septic shock.
    Schusterschitz N; Bellmann R; Stein M; Dunzendorfer S; Pechlaner C; Joannidis M
    Intensive Care Med; 2008 Jul; 34(7):1350-1. PubMed ID: 18297262
    [No Abstract]   [Full Text] [Related]  

  • 15. Anticoagulation with argatroban in patients with heparin-induced thrombocytopenia antibodies after cardiovascular surgery with cardiopulmonary bypass: first results from the ARG-E03 trial.
    Koster A; Buz S; Hetzer R; Kuppe H; Breddin K; Harder S
    J Thorac Cardiovasc Surg; 2006 Sep; 132(3):699-700. PubMed ID: 16935137
    [No Abstract]   [Full Text] [Related]  

  • 16. Anticoagulation with argatroban in a parturient with heparin-induced thrombocytopenia.
    Ekbatani A; Asaro LR; Malinow AM
    Int J Obstet Anesth; 2010 Jan; 19(1):82-7. PubMed ID: 19625181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Argatroban therapy in heparin-induced thrombocytopenia.
    Sparks ML
    AACN Adv Crit Care; 2009; 20(1):37-43. PubMed ID: 19174636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of heparin-induced thrombocytopenia.
    Donovan JL; Tran MT; Kanaan AO
    J Pharm Pract; 2010 Jun; 23(3):226-34. PubMed ID: 21507818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged anticoagulation after discontinuation of argatroban and warfarin therapy in an obese patient with heparin-induced thrombocytopenia.
    Shapiro NL; Durr EA; Krueger CD
    Pharmacotherapy; 2006 Dec; 26(12):1806-10. PubMed ID: 17125442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete salvage of impending free flap failure in heparin induced thrombocytopenia by emergent institution of therapy with argatroban.
    Schleich AR; Oswald TM; Lineaweaver WC
    J Plast Reconstr Aesthet Surg; 2008 Oct; 61(10):1263-4. PubMed ID: 18632316
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.